Mark D. Lim is the Vice President of Research, Discovery, and Innovation at the American Society of Nephrology’s Alliance for Kidney Health (ASN). The department aims to sustain the growth of innovations for people with kidney diseases, building on two public private partnerships with the US Government and KidneyCure, a separate non-profit foundation that supports research fellowships. KidneyX is a partnership with US Department of Health and Human Services that incentivizes entrepreneurs, and the Kidney Health Initiative is a partnership with the US Food and Drug Administration and over 90 member organizations to create regulatory science solutions as a pre-competitive consortium.

Mark also serves on the Scientific Advisory Board of the Quebec Consortium of Drug Discovery, a multi-pharmaceutical and government effort to support the development of drug development technologies. Prior to ASN, Mark supported the biomedical funding strategies of the Bill and Melinda Gates Foundation, Department of Defense, and US National Cancer Institute, and also supported the Milken Institute’s FasterCures. Mark has over 33 publications on global health diagnostic product development, role of public private partnerships, biospecimen science, and nanotechnology, with a PhD in Inorganic Chemistry from UC Santa Barbara and postdoctoral training in Pharmaceutical Chemistry at UC San Francisco.